1
|
American Cancer Society, . Cancer facts
and figures 2016. American Cancer Society; Atlanta, GA: 2016
|
2
|
Ilic M and Ilic I: Colorectal cancer
mortality trends in Serbia during 1991–2010: An age-period-cohort
analysis and a joinpoint regression analysis. Chin J Cancer.
35:552016. View Article : Google Scholar : PubMed/NCBI
|
3
|
Bishehsari F, Mahdavinia M, Vacca M,
Malekzadeh R and Mariani-Costantini R: Epidemiological transition
of colorectal cancer in developing countries: Environmental
factors, molecular pathways, and opportunities for prevention.
World J Gastroenterol. 20:6055–6072. 2014. View Article : Google Scholar : PubMed/NCBI
|
4
|
Abramson RG: Overview of targeted
therapies for cancer. My Cancer Genome. https://www.mycancergenome.org/content/molecular-medicine/overview-of-targeted-therapies-for-cancer/July
29–2016
|
5
|
Gupta A, Kaur CD and Saraf S and Saraf S:
Targeting of herbal bioactives through folate receptors: A novel
concept to enhance intracellular drug delivery in cancer therapy. J
Recept Signal Transduct Res. 1–10. 2017.
|
6
|
Matsumoto K, Umitsu M, De Silva DM, Roy A
and Bottaro DP: HGF-MET in cancer progression and biomarker
discovery. Cancer Sci. Jan 8–2017.(Epub ahead of print). View Article : Google Scholar
|
7
|
Bozzi F, Mogavero A, Varinelli L, Belfiore
A, Manenti G, Caccia C, Volpi CC, Beznoussenko GV, Milione M, Leoni
V, et al: MIF/CD74 axis is a target for novel therapies in colon
carcinomatosis. J Exp Clin Cancer Res. 36:162017. View Article : Google Scholar : PubMed/NCBI
|
8
|
Li X, Zhang G, Wang Y, Elgehama A, Sun Y,
Li L, Gu Y, Guo W and Xu Q: Loss of periplakin expression is
associated with the tumorigenesis of colorectal carcinoma. Biomed
Pharmacother. 87:366–374. 2017. View Article : Google Scholar : PubMed/NCBI
|
9
|
Chen W, Chen X and Lou R: Clinical study
on lymph node metastasis of colorectal cancer. Chin J Cancer.
19:479–480. 2000.(in Chinese).
|
10
|
Grady WM and Carethers JM: Genomic and
epigenetic instability in colorectal cancer pathogenesis.
Gastroenterology. 135:1079–1099. 2008. View Article : Google Scholar : PubMed/NCBI
|
11
|
Sen S: Aneuploidy and cancer. Curr Opin
Oncol. 12:82–88. 2000. View Article : Google Scholar : PubMed/NCBI
|
12
|
Pérez-Torras S, Vidal-Pla A, Cano-Soldado
P, Huber-Ruano I, Mazo A and Pastor-Anglada M: Concentrative
nucleoside transporter 1 (hCNT1) promotes phenotypic changes
relevant to tumor biology in a translocation-independent manner.
Cell Death Dis. 4:e6482013. View Article : Google Scholar : PubMed/NCBI
|
13
|
Shivakumar BM, Rotti H, Vasudevan TG,
Balakrishnan A, Chakrabarty S, Bhat G, Rao L, Pai CG and
Satyamoorthy K: Copy number variations are progressively associated
with the pathogenesis of colorectal cancer in ulcerative colitis.
World J Gastroenterol. 21:616–622. 2015. View Article : Google Scholar : PubMed/NCBI
|
14
|
Chen Z, Liu Z, Deng X, Warden C, Li W and
Garcia-Aguilar J: Chromosomal copy number alterations are
associated with persistent lymph node metastasis after
chemoradiation in locally advanced rectal cancer. Dis Colon Rectum.
55:677–685. 2012. View Article : Google Scholar : PubMed/NCBI
|
15
|
Liang JW, Shi ZZ, Zhang TT, Hao JJ, Wang
Z, Wang XM, Yang H, Wang MR, Zhou ZX and Zhang Y: Analysis of
genomic aberrations associated with the clinicopathological
parameters of rectal cancer by array-based comparative genomic
hybridization. Oncol Rep. 29:1827–1834. 2013.PubMed/NCBI
|
16
|
Sawada T, Yamamoto E, Suzuki H, Nojima M,
Maruyama R, Shioi Y, Akasaka R, Kamimae S, Harada T, Ashida M, et
al: Association between genomic alterations and metastatic behavior
of colorectal cancer identified by array-based comparative genomic
hybridization. Genes Chromosomes Cancer. 52:140–149. 2013.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-tie quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Maurer G, Tarkowski B and Baccarini M: Raf
kinases in cancer-roles and therapeutic opportunities. Oncogene.
30:3477–3488. 2011. View Article : Google Scholar : PubMed/NCBI
|
19
|
Kajanne R, Miettinen P, Mehlem A, Leivonen
SK, Birrer M, Foschi M, Kähäri VM and Leppä S: EGF-R regulates MMP
function in fibroblasts through MAPK and AP-1 pathways. J Cell
Physiol. 212:489–497. 2007. View Article : Google Scholar : PubMed/NCBI
|
20
|
Verma N, Keinan O, Selitrennik M, Karn T,
Filipits M and Lev S: PYK2 sustains endosomal-derived receptor
signalling and enhances epithelial-to-mesenchymal transition. Nat
Commun. 6:60642015. View Article : Google Scholar : PubMed/NCBI
|
21
|
Inoue H, Miyazaki Y, Kikuchi K, Yoshida N,
Ide F, Ohmori Y, Tomomura A, Sakashita H and Kusama K: Podoplanin
expression during dysplasia-carcinoma sequence in the oral cavity.
Tumour Biol. 33:183–194. 2012. View Article : Google Scholar : PubMed/NCBI
|
22
|
Zhang F, Zhang X, Li M, Chen P, Zhang B,
Guo H, Cao W, Wei X, Cao X, Hao X and Zhang N: mTOR complex
component Rictor interacts with PKCzeta and regulates cancer cell
metastasis. Cancer Res. 70:9360–9370. 2010. View Article : Google Scholar : PubMed/NCBI
|
23
|
Hardy KM, Booth BW, Hendrix MJ, Salomon DS
and Strizzi L: ErbB/EGF signaling and EMT in mammary development
and breast cancer. J Mammary Gland Biol Neoplasia. 15:191–199.
2010. View Article : Google Scholar : PubMed/NCBI
|
24
|
Kim HD, Meyer AS, Wagner JP, Alford SK,
Wells A, Gertler FB and Lauffenburger DA: Signaling network state
predicts twist-mediated effects on breast cell migration across
diverse growth factor contexts. Mol Cell Proteomics.
10:M111.008433. 2011. View Article : Google Scholar
|
25
|
Bracher A, Cardona AS, Tauber S, Fink AM,
Steiner A, Pehamberger H, Niederleithner H, Petzelbauer P, Gröger M
and Loewe R: Epidermal growth factor facilitates melanoma lymph
node metastasis by influencing tumor lymphangiogenesis. J Invest
Dermatol. 133:230–238. 2013. View Article : Google Scholar : PubMed/NCBI
|
26
|
Rovenská E: Importance of
lymphangiogenesis and ultrastructure of lymphatic capillaries in
metastasis of malignant melanoma. Vnitr Lek. 60:582–585.
2014.PubMed/NCBI
|